Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 7, 2010; 16(37): 4725-4732
Published online Oct 7, 2010. doi: 10.3748/wjg.v16.i37.4725
Published online Oct 7, 2010. doi: 10.3748/wjg.v16.i37.4725
Antibody | Clone | Source | Dilution |
Vimentin (M) | Vim3B4 | Dako (Glostrup, Denmark) | 1:100 |
α-1-antitrypsin (P) | Changdao (Shanghai, China) | 1:100 | |
Cytokeratin 18 (M) | DC10 | Dako (Glostrup, Denmark) | 1:25 |
Cytokeratin 19 (M) | RCK108 | Dako (Glostrup, Denmark) | 1:50 |
CD68 (M) | PG-M1 | Changdao (Shanghai, China) | 1:50 |
CD56 (M) | 123C3 | Dako (Glostrup, Denmark) | 1:50 |
Desmin (M) | D33 | Dako (Glostrup, Denmark) | 1:50 |
α-SMA (M) | 1A4 | Dako (Glostrup, Denmark) | 1:50 |
Myoglobin (M) | MYO18 | Dako (Glostrup, Denmark) | 1:50 |
CD117 (P) | Changdao (Shanghai, China) | 1:50 | |
S-100 (M) | 4C4.9 | Changdao (Shanghai, China) | 1:200 |
CD34 (M) | QBEnd10 | Dako (Glostrup, Denmark) | 1:25 |
Melanosome (M) | HMB-45 | Dako (Glostrup, Denmark) | 1:25 |
Hep Par 1 (M) | OCH1E5 | Dako (Glostrup, Denmark) | 1:50 |
AFP (M) | AF04 | Changdao (Shanghai, China) | 1:100 |
HBsAg (M) | 3E7 | Dako (Glostrup, Denmark) | 1:50 |
p53 (M) | DO-7 | Dako (Glostrup, Denmark) | 1:50 |
pCEA (P) | Changdao (Shanghai, China) | 1:200 | |
mCEA (M) | COL-1 | Changdao (Shanghai, China) | 1:50 |
EMA (M) | E29 | Dako (Glostrup, Denmark) | 1:50 |
NSE (M) | E27 | Changdao (Shanghai, China) | 1:50 |
Chromogranin A (M) | DAK-A3 | Dako (Glostrup, Denmark) | 1:100 |
Synaptophysin (M) | SY38 | Dako (Glostrup, Denmark) | 1:20 |
Ki67 (M) | MIB-1 | Dako (Glostrup, Denmark) | 1:100 |
No. | Ref. | Yr | Sex | Age (yr) | Symptoms and signs | Laboratory findings | Location | Size (cm) | Surgery | Adjuvanttreatment | Recurrence | Follow-up |
1 | Esposito et al[6] | 1977 | M | 36 | RUQA pain, hepatomegaly, jaundice | ↑Bil, AST, ALT | R + L | NA | Liver biopsy | No | NA | DOD 2 mo |
2 | Tanner et al[7] | 1978 | F | 66 | RUQA pain, vomiting, diarrhea, weight loss, fever, hepatomegaly | ↑ALP | R | NA | HA ligation | No/5-FU | v | AWD 3 yr |
3 | Chang et al[8] | 1983 | F | 55 | RUQA pain, weight loss, diarrhea, hepatomegaly | ↑ALT | L | 10 × 10 × 8 | Left lob | No/CAV | No | ANED 1 mo |
4 | Ellis et al[9] | 1983 | F | 86 | RUQA pain and mass | Normal | R | 18 × 12 × 12 | Wedge resec | No | Yes | DOD 8 wk |
5 | Forbes et al[10] | 1987 | M | 69 | RUQA pain, nausea, weight loss, hepatomegaly | Normal | NA | NA | No | RT/RT | NA | DOD 10 mo |
6 | Forbes et al[10] | 1987 | F | 49 | RUQA pain, nausea, weight loss, hepatomegaly | NA | NA | NA | No | No | NA | NA |
7 | Zornig et al[11] | 1992 | M | 42 | RUQA pain | Normal | R | 8 | Biseg | adm + ifs | No | ANED 30 mo |
8 | Zaheer et al[12] | 1994 | F | 44 | RUQA pain and mass, weight loss, fever | ↑AFP | R | 10 | Liver biopsy | adm | NA | DOD 1 wk |
9 | Grazi et al[13] | 1996 | F | 60 | Dyspepsia, RUQA mass | Normal | R | 22 | Rx Hep | No | Yes | DOD 11 mo |
10 | Nishio et al[3] | 2003 | F | 49 | RUQA pain | NA | R | 14 × 8 × 8 | Rx lob | No | Yes | DOD 29 mo |
11 | Nishio et al[3] | 2003 | M | 62 | RUQA pain | NA | L | 10 × 9 × 7 | Left lob | No | No | ANED 10 mo |
12 | Lepreux et al[14] | 2005 | F | 51 | RUQA pain | ↑AFP | R | NA | No | VAC | NA | Dead 2 mo |
13 | Lepreux et al[14] | 2005 | F | 49 | RUQA pain | Normal | L | NA | Left lob | ifs + dtic + adm | No | ANED 6 mo |
14 | Agaram et al[15] | 2006 | F | 33 | NA | NA | NA | 14.5 | NA | NA | No | ANED 6 mo |
15 | Agaram et al[15] | 2006 | F | 50 | NA | NA | NA | 17 | NA | NA | No | ANED 8 mo |
16 | Scudiere et al[4] | 2006 | F | 51 | Pneumonia | ↑AST, ALT | R | 25 × 19 × 8.5 | Rx lob | NA | NA | NA |
17 | Ma et al[16] | 2008 | F | 61 | RUQA pain | Normal | R | 12 × 9 × 8 | Rx hep | NA | NA | DOD 8 mo |
18 | Yang et al[17] | 2009 | M | 46 | RUQA pain and fever | ↑AST, ALT, GGT | R | 6.2 × 5.9 × 5.4 | Rx hep | NA | NA | NA |
19 | Yang et al[17] | 2009 | M | 54 | RUQA pain and fever | ↑AST, ALT, GGT | R | 13 × 11.7 × 12.4 | Rx hep | NA | NA | NA |
20 | Xu et al[18] | 2010 | F | 36 | RUQA pain | Normal | L | 30 × 25 × 15 | Rx hep | NA | NA | NA |
21 | Present case 1 | M | 63 | RUQA pain and fever | ↑AKP | R | 15 × 15 × 20 | Rx hep | NA | Yes | DOD 18 mo | |
22 | Present case 2 | M | 39 | weight lose and fever | ↑AKP | L | 16 × 13 × 9 | Left lob | TACE | Yes | DOD 32 mo | |
23 | Present case 3 | M | 56 | RUQA pain | ↑AKP, ALT, AST, GGT | R | 12.5 × 11.5 | Rx hep | TACE | Yes | DOD 28 mo | |
24 | Present case 4 | F | 43 | RUQA pain | ↑AKP | R | 14 × 12 × 10 | Rx hep | NA | Yes | DOD 24 mo |
Antibody | Case 1 | Case 2 | Case 3 | Case 4 | |
Primary | Recurrent | ||||
Age (yr)/sex | 63/M | 39/M | 56/M | 43/F | 44/F |
Vimentin | + | + | + | + | + |
α-1-antitrypsin | + | + | + | + | + |
Cytokeratin 18 | +F | +F | - | +F | +F |
Cytokeratin 19 | +F | +F | - | +F | +F |
CD68 | + | + | + | + | + |
CD56 | + | + | + | + | + |
Desmin | - | +F | +F | - | +F |
α-SMA | - | - | - | - | +F |
Myoglobin | - | - | - | - | +F |
CD117 | - | - | - | - | - |
S-100 | - | - | - | - | +F |
CD34 | - | - | - | - | +F |
HMB45 | - | - | - | - | - |
Hep Par 1 | - | - | - | - | - |
AFP | - | - | - | - | - |
HBsAg | - | - | - | - | - |
p53 | - | - | + | + | + |
pCEA | - | - | - | - | - |
mCEA | - | - | - | - | - |
EMA | - | - | - | - | - |
NSE | - | - | - | - | - |
Chromogranin A | - | - | - | - | - |
Synaptophysin | - | - | - | - | - |
Ki67 | 60% | 50% | 45% | 40% | 65% |
- Citation: Li XW, Gong SJ, Song WH, Zhu JJ, Pan CH, Wu MC, Xu AM. Undifferentiated liver embryonal sarcoma in adults: A report of four cases and literature review. World J Gastroenterol 2010; 16(37): 4725-4732
- URL: https://www.wjgnet.com/1007-9327/full/v16/i37/4725.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i37.4725